BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 17019971)

  • 1. Sodium metavanadate affected control and streptozotocin-diabetic rat liver golgi complexes.
    Dabroś W; Goc A; Turyna B; Kordowiak AM
    Pol J Pathol; 2006; 57(2):91-7. PubMed ID: 17019971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of BMOV [bis(maltolato)oxovanadium(IV)] on biochemical and morphological alterations characteristic for streptozotocin-diabetic rat liver Golgi complexes.
    Dabroś W; Dziga D; Kordowiak AM
    Pol J Pathol; 2002; 53(4):205-13. PubMed ID: 12597338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium orthovanadate exerts influence on liver Golgi complexes from control and streptozotocin-diabetic rats.
    Kordowiak AM; Goc A; Drozdowska E; Turyna B; Dabros W
    J Inorg Biochem; 2005 May; 99(5):1083-9. PubMed ID: 15833331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of a new vanadium compound, bis(2,2'-bipyridine)oxovanadium(IV) sulphate on liver golgi complexes from control and streptozotocin-diabetic rats.
    Kordowiak AM; Dabroś W; Kajda B
    Horm Metab Res; 2002 Oct; 34(10):556-60. PubMed ID: 12439783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of bis(maltolato)oxovanadium(IV) on activity of galactosyltransferase (GalT) and morphology of rat liver Golgi apparatus in control and streptozotocin diabetes.
    Dabroś W; Kordowiak AM; Dziga D; Gryboś R
    Pol J Pathol; 1998; 49(2):67-76. PubMed ID: 9798409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like effects on liver Golgi membrane preparations of bis(oxalato)oxovanadate(IV) complex ion, a new vanadate compound.
    Kordowiak AM; Trzos R; Grybos R
    Horm Metab Res; 1997 Mar; 29(3):101-5. PubMed ID: 9137978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptozotocin-induced alterations in rat liver Golgi complexes are ameliorated by BMOV [Bis(maltolato)oxovanadium(IV)] activity.
    Kordowiak AM; Dziga D; Dabroś W
    Horm Metab Res; 2004 Mar; 36(3):148-54. PubMed ID: 15057667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control and STZ-diabetic rat liver Golgi complexes under the influence of bis(2,2'-bipyridine)oxovanadium(IV) sulphate. The morphological investigation.
    Dabroś W; Kajda B; Kordowiak AM
    Pol J Pathol; 2002; 53(3):123-8. PubMed ID: 12476613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and morphological study on liver Golgi complex in streptozotocin-diabetic and control rats treated with bis(kojato)oxovanadium(IV) [VO(ka)2]x2H2O. Part II. Prolonged treatmentwith vanadium compound.
    Dabroś W; Gryboś R; Miarka A; Kordowiak AM
    Pol J Pathol; 2000; 51(1):17-24. PubMed ID: 10833899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphology and biochemical activity of rat liver golgi complexes after pretreatment with bis(kojato)oxovanadium(IV) or kojic acid alone.
    Dabroś W; Nikiforuk A; Kordowiak AM
    Pol J Pathol; 2004; 55(3):15-21. PubMed ID: 15619976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and morphological study on liver Golgi complex in streptozotocin-diabetic and control rats treated with bis(kojato)oxovanadium(IV) [VO(ka)2]x2H2O. Part I. One week treatment with vanadium compound.
    Kordowiak AM; Nikiforuk A; Dabroś W
    Pol J Pathol; 2000; 51(1):9-16. PubMed ID: 10833898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of LEPK on biochemical activity and morphology in situ of liver Golgi apparatus from control and streptozotocin-diabetic rats.
    Kordowiak AM; Polański M; Dabroś W
    Pol J Pathol; 1997; 48(2):87-93. PubMed ID: 9278104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and morphological alterations in rat liver Golgi complexes after treatment with bis(maltolato)oxovanadium(IV) [BMOV] or maltol alone.
    Dabroś W; Dziga D; Gryboś R; Kordowiak AM
    Pathol Res Pract; 2000; 196(8):561-8. PubMed ID: 10982019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of vanadyl sulphate [VOSO4] on biochemical activity and morphology of control and streptozotocin-diabetic rat liver Golgi complexes.
    Dabroś W; Goc A; Turyna B; Kordowiak AM
    Pol J Pathol; 2004; 55(1):25-32. PubMed ID: 15195703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of bipyridyl, maltol and kojic acid action as organic vanadium ligands on activity of galactosyltransferase (EC 2.4.1.38), some physiological parameters and ultrastructure of Golgi complexes in rat hepatocytes.
    Dabros W; Kordowiak A
    Folia Histochem Cytobiol; 2007; 45(3):239-44. PubMed ID: 17951174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral vanadate and Tiron in treatment of diabetes mellitus in rats: improvement of glucose homeostasis and negative side-effects.
    Domingo JL; Sanchez DJ; Gomez M; Llobet JM; Corbella J
    Vet Hum Toxicol; 1993 Dec; 35(6):495-500. PubMed ID: 8303815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective control of blood glucose status and toxicity in streptozotocin-induced diabetic rats by orally administration of vanadate in an herbal decoction.
    Zhang L; Zhang Y; Xia Q; Zhao XM; Cai HX; Li DW; Yang XD; Wang K; Xia ZL
    Food Chem Toxicol; 2008 Sep; 46(9):2996-3002. PubMed ID: 18601969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.
    Li M; Ding W; Smee JJ; Baruah B; Willsky GR; Crans DC
    Biometals; 2009 Dec; 22(6):895-905. PubMed ID: 19404749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
    Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats.
    Saad SY; Najjar TA
    Arch Toxicol; 2005 Sep; 79(9):493-9. PubMed ID: 15940472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.